About 4dm1n_diversatechnologies

This author has not yet filled in any details.
So far 4dm1n_diversatechnologies has created 8 blog entries.

A biotech spin-off company among the winners of the PEL awards

DIVERSA has been awarded the prestigious award by the “Deputación da Coruña” among several emerging companies.   The rationale of PEL awards   The PEL awards are part of the Local Employment Plan of the “Deputación da Coruña”. It is a strong commitment to entrepreneurship, [...]

2022-09-26T11:12:15+00:00September 26, 2022|Company news|

DIVERSA achieves the ‘Galician Excellence’

Our CEO and co-founder Maria de la Fuente received the Title of Galician Excellence from the Association of Galician Entrepreneurs in Catalonia.   Already contributing to economic development   The Association of Galician Entrepreneurs in Catalonia held its annual gala, an event in which the [...]

2022-09-26T11:13:12+00:00September 22, 2022|Company news|

DIVERSA plans to grow internationally with the support of the ICEX NEXT program

DIVERSA has been selected under the ICEX NEXT program on a competitive basis amongst more than 150 Spanish SMEs, and here we tell you how this opportunity could help us be more competitive internationally.   What is ICEX NEXT?   The Foreign Trade Institute (ICEX), [...]

2022-09-26T11:13:44+00:00September 12, 2022|Company news|

Small molecules: towards clinical development

The potential of nanomedicine to provide therapeutic benefits over conventional drug formulations has been proven with other drugs in the market. One example of success is DOXIL®, a liposome-based doxorubicin formulation which improves pharmacokinetic profile. In the same direction, DIVERSA aims to bridge the gap [...]

2022-09-09T13:28:42+00:00September 8, 2022|Blog|

Improving the fate of protein therapeutics

The potential of proteins for the treatment of diseases Protein therapeutics represent a powerful field for the treatment of many diseases, having shown its potential for several years; especially since the ‘boom’ of recombinant protein production. When compared to traditional small molecule therapeutic approach, proteins bring [...]

2022-09-08T10:20:29+00:00May 3, 2022|Blog|
Go to Top